Showing posts with label Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Show all posts
Showing posts with label Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Show all posts
Wednesday, December 20, 2017

FDA Expands Approval of Sprycel (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase

›
In continuation of my update on  Sprycel ( dasatinib ) Bristol-Myers Squibb Company (NYSE:BMY) announced the U.S. Food and Drug A...